Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Susan G. Komen Supplement to Promote Inclusion for Research Excellence (ASPIRE)

Susan G. Komen

PURPOSE OF AWARD:
This Susan G. Komen grant mechanism is intended to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research. By supporting these promising trainees early in their research careers, Komen seeks to ensure that a diverse group of highly trained scientists who reflect the communities we serve will emerge as the next generation of leaders in breast cancer research and end breast cancer forever.

Trainee supported by supplement grant:
• Trainees supported with this supplement are from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data, including Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders, and individuals with disabilities, as well as individuals from disadvantaged backgrounds according to the criteria used by the NIH (https://extramural-diversity.nih.gov/diversity-matters/get-the-facts).
• Must be at the same institution as the Lead Mentor

• Must be able to devote at least 75% of full-time effort to breast cancer research and activities, i.e., protected research time.

• Predoctoral and health professional students:
o Must be a full-time student working towards their degree and enrolled in a Ph.D., M.D./Ph.D., or any other research-intensive graduate degree.
o At time of award activation must have completed qualifying exams and be in a research portion of their training programs (Ph.D., M.D./Ph.D., and any other research-intensive graduate degrees are eligible) where they can devote full-time effort to research activities and development as a breast cancer researcher.

• Postdoctoral Fellows:
o Must have a doctoral degree, such as M.D., Ph.D., Dr.P.H., D.O., or equivalent.
o Must have no more than 4 years of research training or experience since obtaining their doctoral degree (excluding clinical training or leaves of absence, e.g., maternity/paternity/sick leave) and the intention of pursuing an independent research career.
o May not hold a faculty appointment.
o Medical Fellows must be on a research track with protected research time.

Institution
• Must be a non-profit institution in the United States.
• May not be a governmental agency (e.g., NIH, NCI, etc.).
• Must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants.

FUNDING INFORMATION AND GRANT TERM
PIs/Lead Mentors may request funding of up to $100,000 per year (direct costs only) for one or two years depending on the trainee’s career level and years of funding remaining for the PI’s funded breast cancer study.
The purpose of the ASPIRE award is to support the Trainee’s salary and career development. Actual research costs should be covered by the PI’s other funding. Applicants/PIs/Lead Mentors should take note of the following budget guidelines for the supplement grant budget.
In all cases:
• Publication costs and meeting-related poster printing costs ARE allowed for purposes specifically related to the proposed Research Project.
• Professional membership fees ARE NOT allowed with this supplement to attend a scientific conference. However, membership fees ARE allowed to join minority focused and serving organizations, e.g., National Medical Association, Society of Black Academic Surgeons, Society for Advancement of Chicanos/Hispanics, Native Americans in Science (SACNAS), etc.
• Research supply and equipment costs ARE NOT allowed. (All research costs must be covered by the PI’s other funding)
• Visa costs ARE NOT allowed.
• Computing costs ARE NOT allowed.
• Patient care costs ARE NOT allowed.
• Reasonable compensation of Patient Advocates is allowed when advocates perform services that would otherwise be a contracted expense. Compensation may be in the form of per-hour compensation, or honoraria.
• Tuition and course fees ARE ONLY ALLOWED for pre-doctoral trainees, but not postdoctoral trainees. Both ARE ALLOWED to attend workshops and have workshop fees covered.
• Indirect costs ARE NOT allowed. Indirect costs include all expenses not directly related to the conduct of the Research Project, including, but not limited to, allocated costs such as facilities, technology support, communication expenses, administrative support, etc.
• Travel costs ARE allowed for the pre-doctoral or postdoctoral trainee (see details below).

Specialties

Cancer

Oncology

Women's Health

Gynecology

Radiation Oncology

Eligibility Requirements

Applicants/PIs/Lead Mentors, Trainees and Institutions must conform to the following eligibility criteria to apply for a Grant Supplement. Eligibility requirements must be met at the time of Application submission (November 04, 2024).

Applicant/PI/Lead Mentor
The Applicant/PI will serve as the Lead Mentor for the Trainee supported by this grant supplement. The primary purpose of the Lead Mentor is to provide the research, scientific, clinical, management, and leadership guidance necessary to foster the Trainee’s career advancement and the successful development of the proposed research project. The Lead Mentor should be active in the field of breast cancer and committed both to the training and career development of the trainee and to the direct supervision of the Trainee’s research.
• Must have a currently funded breast cancer research project that has undergone a rigorous peer review by Susan G. Komen, the Department of Defense, the National Institutes of Health (NIH) or the National Science Foundation (NSF) or comparable.
• Funded project must have at least one year of grant funds remaining at the time of announcement of award (on or around April 15, 2025).
• Must hold a tenure-track faculty position at an institution in the United States with adequate spacing for an additional trainee.
• Is not required to be a U.S. citizen or permanent resident.
• May only submit ONE Application per funding cycle, i.e., may not be PI/lead Mentor on another grant application in that funding cycle. The mentor may be a PI/Lead Mentor on a previously funded ASPIRE grant, but the new application must be for another trainee on another breast cancer-focused project supported by a different research grant.
• Must ensure that all past and current Komen-funded Grants are up to date and in compliance with all Komen requirements, e.g., progress report submissions, IRB approvals, etc. by the Application due date (November 04, 2024).

Sponsor Details

Sponsor Institute/Organizations: Susan G. Komen

Sponsor Type:

Address: 13770 Noel Road, PO Box 801889 Dallas, TX 75380

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity